Louisiana HB1223 establishes the Louisiana Early-Phase Clinical Trial Acceleration Framework to improve clinical trial efficiency and patient access.

Louisiana HB1223 creates the Louisiana Early-Phase Clinical Trial Acceleration Framework to enhance the speed and predictability of early-phase clinical trials in the state. The framework mandates participation from all entities conducting covered clinical projects in Louisiana. Research entities must enter into participation agreements with the Louisiana Economic Development department, establishing expectations for benchmark categories, primary contacts, and other coordination functions.

Louisiana HB1223 establishes the Louisiana Early-Phase Clinical Trial Acceleration Framework to improve clinical trial efficiency and patient access.

Louisiana HB1223 creates the Louisiana Early-Phase Clinical Trial Acceleration Framework to enhance the speed and predictability of early-phase clinical trials in the state. The framework mandates participation from all entities conducting covered clinical projects in Louisiana. Research entities must enter into participation agreements with the Louisiana Economic Development department, establishing expectations for benchmark categories, primary contacts, and other coordination functions.